Literature DB >> 35921019

Does diagnostic testing always decrease antibiotics prescriptions?

F Antoñanzas1, C A Juárez-Castelló1, R Rodríguez-Ibeas2.   

Abstract

BACKGROUND: Empiric prescription to treat infectious diseases in community care settings has caused antibiotics to be overprescribed, increasing antimicrobial resistance (AMR). To reduce antibiotics prescription, the use of point-of-care diagnostic testing (POCT) has been suggested.
METHODS: We present a stylized static theoretical economic model to analyse whether the use of POCT always decreases antibiotics prescriptions. We consider the interaction of a group of doctors who differ in their level of concern about AMR when prescribing with a firm selling a POCT, and we characterize the price set by the manufacturer and doctors' decision to employ POCT.
RESULTS: We found that the number of antibiotics prescriptions is not always lower. This result depends on the distribution of the doctors' concern about AMR as there is a proportion of doctors who use POCT and then prescribe antibiotics while other doctors change their prescribing behaviour after using POCT and stop giving antibiotics to patients who do not benefit from them. When the proportion of patients who need antibiotic treatment is higher than the proportion of doctors who use POCT and stop prescribing unnecessary antibiotics, the number of antibiotics prescriptions is larger. Our analysis also shows that the use of POCT improves health outcomes.
CONCLUSIONS: We should be very careful when we assert that POCT reduces antibiotics prescriptions as there are situations in which the opposite effect occurs.
© 2022. The Author(s).

Entities:  

Keywords:  Antibiotics; Antimicrobial resistances; Diagnostic tests; Infectious diseases; Prescriptions

Year:  2022        PMID: 35921019     DOI: 10.1007/s10198-022-01488-0

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  6 in total

1.  Actual versus 'ideal' antibiotic prescribing for common conditions in English primary care.

Authors:  Koen B Pouwels; F Christiaan K Dolk; David R M Smith; Julie V Robotham; Timo Smieszek
Journal:  J Antimicrob Chemother       Date:  2018-02-01       Impact factor: 5.790

2.  Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use.

Authors:  Poojan Shrestha; Ben S Cooper; Joanna Coast; Raymond Oppong; Nga Do Thi Thuy; Tuangrat Phodha; Olivier Celhay; Philippe J Guerin; Heiman Wertheim; Yoel Lubell
Journal:  Antimicrob Resist Infect Control       Date:  2018-08-09       Impact factor: 4.887

3.  Health-Economic Analyses of Diagnostics: Guidance on Design and Reporting.

Authors:  Simon van der Pol; Paula Rojas Garcia; Fernando Antoñanzas Villar; Maarten J Postma; Antoinette D I van Asselt
Journal:  Pharmacoeconomics       Date:  2021-11-01       Impact factor: 4.981

4.  Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries.

Authors:  C C Butler; K Hood; T Verheij; P Little; H Melbye; J Nuttall; M J Kelly; S Mölstad; M Godycki-Cwirko; J Almirall; A Torres; D Gillespie; U Rautakorpi; S Coenen; H Goossens
Journal:  BMJ       Date:  2009-06-23

5.  Modelling the Impact and Cost-Effectiveness of Biomarker Tests as Compared with Pathogen-Specific Diagnostics in the Management of Undifferentiated Fever in Remote Tropical Settings.

Authors:  Yoel Lubell; Thomas Althaus; Stuart D Blacksell; Daniel H Paris; Mayfong Mayxay; Wirichada Pan-Ngum; Lisa J White; Nicholas P J Day; Paul N Newton
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

6.  Using point-of-care diagnostic testing for improved antibiotic prescription: an economic model.

Authors:  F Antoñanzas; C A Juárez-Castelló; R Rodríguez-Ibeas
Journal:  Health Econ Rev       Date:  2021-08-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.